MetGen as a company has focused on lignocellulosic biomass.
That is our business strategy, what is yours?
ENZINE® technology platform is enzyme agnostic. In other words, our platform can be utilized to improve any enzyme, focusing on biomass also other than our strategic focus and enzyme strains.
Our typical cooperation is divided into two phases. At the first phase MetGen will screen potential enzymes and best strains to work with, introducing the results to the customer. After the first phase our modular approach, if the results are favorable and desirable for the customer, can move to the second phase of genetic engineering and scale up of production. Before moving into the second phase, the best candidates for the customer’s process are carefully inspected and different options for the production discussed.